Toshiyuki Harada

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations

Medicine, Oncology, Pharmacology +13

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo et al. · Annals of Oncology · 2012 · 554 citations

Medicine, Oncology, Pharmacology +15

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study

Yukio Hosomi, Satoshi Morita, Shunichi Sugawara et al. · Journal of Clinical Oncology · 2019 · 483 citations

Medicine, Oncology, Pharmacology +14

Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy

Hiroki Shirato, Toshiyuki Harada, Tooru Harabayashi et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 351 citations

Medicine, Biomedical Engineering, Oncology +16

Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy

Mikado Imura, Koichi Yamazaki, Hiroki Shirato et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 176 citations

Medicine, Radiation Oncology, Radiology +13